HHTM

Can a unified network of patients, clinicians, and researchers finally transform tinnitus care? The team at Stop The Ring presents an ambitious plan to do just that with the creation of a Tinnitus Learning Health Network. Originally presented at the InFocus: Rethinking Tinnitus Symposium and moderated by Dr. David Holcomb, this discussion brings together Jeffery Reagan, a tinnitus patient and founder

WHITE BEAR LAKE, MINNESOTA – Envoy Medical®, Inc. (NASDAQ: “COCH”), a hearing health company dedicated to developing innovative solutions for hearing loss, announced the issuance of four new patents. The U.S. Patent & Trademark Office issued Envoy Medical Corporation U.S. Patent No. 12,151,102 on November 25, 2024. Titled Combination Hearing Aid and Cochlear Implant System, the patent focuses on updating

MILAN, ITALY – Amplifon, a global leader in hearing solutions and services, announced the signing of a new sustainability-linked credit facility with Mediobanca – Banca di Credito Finanziario S.p.A., for a total amount of €75 million (~$80.2M USD). This loan, amortizing with a 5-year term, builds on Amplifon’s existing five sustainability-linked credit facilities, reflecting the company’s commitment to further integrating

MONTPELLIER, FRANCE – Sensorion (FR0012596468 – ALSEN), a clinical-stage biotechnology company specializing in therapies to restore, treat, and prevent hearing loss disorders, has announced promising data from the first two patients treated in the Audiogene Phase 1/2 clinical trial evaluating SENS-501. This trial focuses on infants and toddlers aged 6 to 31 months who suffer from a specific form of

ITASCA, ILLINOIS — Knowles Corporation (NYSE: KN), a provider of high-performance capacitors, radio frequency (RF) filtering products, advanced micro-acoustic microphones, and balanced armature speakers, will unveil its latest audio technologies at CES 2025.The company will demonstrate innovations designed for hearing health, true wireless stereo (TWS), open wearable stereo (OWS), and audiophile applications. CES attendees can visit Knowles at the Venetian

EDEN PRAIRIE, MINNESOTA – Starkey has announced that its Founder and Chairman, William F. Austin, has been awarded an honorary degree from Kenyatta University in recognition of his groundbreaking contributions to hearing healthcare and his unwavering commitment to serving disadvantaged communities in Africa and throughout the world. Bill Austin’s vision and generosity have touched millions of lives around the globe.

SOMERSET, NEW JERSEY — On December 6th, Oticon President Gary Rosenblum and Mariann Cadieu, Executive Director of the Oticon Hearing Foundation, visited Mary’s Place by the Sea—a respite home dedicated to supporting women battling cancer. The facility received a generous donation raised through the dedicated efforts of Demant staff volunteers and sales promotions. During their visit, the team toured the

Shyam Gollakota, a professor at the University of Washington and digital health innovator, is pioneering a revolutionary solution to the ‘cocktail party problem,’ a longstanding challenge in hearing technology. His team has created a groundbreaking “sound bubble” device that enables users to amplify voices within a specific range while minimizing external noise and distractions. Designed to adapt dynamically to different

Hearing loss, a condition affecting millions globally, often extends beyond the obvious symptoms captured by standard audiograms. Up to 10% of patients experiencing hearing difficulties have conditions that remain undiagnosed through conventional clinical tests. Addressing this unmet need, researchers at the University of Pittsburgh have developed a groundbreaking diagnostic tool for detecting hidden hearing pathologies, offering new hope for improved

SEATTLE, WASHINGTON — Sound Pharmaceuticals announced today that its pivotal Phase 3 clinical trial evaluating SPI-1005, a novel anti-inflammatory compound (ebselen), for the treatment of Meniere’s Disease (STOPMD-3) successfully met its co-primary efficacy endpoints. These results demonstrate significant improvements in hearing loss and speech discrimination. Meniere’s disease (MD) is an inner ear disorder that causes fluctuating hearing loss, tinnitus, and